Analysis of Molecular Mechanism of Erxian Decoction in Treating Osteoporosis Based on Formula Optimization Model

Osteoporosis (OP) is a highly prevalent orthopedic condition in postmenopausal women and the elderly. Currently, OP treatments mainly include bisphosphonates, receptor activator of nuclear factor kappa-B ligand (RANKL) antibody therapy, selective estrogen receptor modulators, teriparatide (PTH1-34),...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lang, Fan, Liuyi, Wang, Kexin, Chen, Yupeng, Liang, Lan, Qin, Xuemei, Lu, Aiping, Cao, Peng, Yu, Bin, Guan, Daogang, Peng, Junxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238601/
https://www.ncbi.nlm.nih.gov/pubmed/34239693
http://dx.doi.org/10.1155/2021/6641838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238601/
https://www.ncbi.nlm.nih.gov/pubmed/34239693
http://dx.doi.org/10.1155/2021/6641838

Ejemplares similares